DNA - Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A
Close
6.69
-0.400 -5.979%
Share volume: 1,444,209
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
PREVIOUS CLOSE
CHG
CHG%
$7.09
-0.40
-5.64%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-14 | 2023-03-13 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-02-29 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 1.994 B | 1.871 B | 2.539 B | 2.417 B | 2.292 B | 2.026 B | 1.665 B | 1.582 B | |
| Current Assets | 1.599 B | 1.462 B | 1.450 B | 1.327 B | 1.223 B | 1.142 B | 1.002 B | 903.020 M | |
| Inventories | 8.102 M | 5.860 M | 4.364 M | 2.509 M | 391.000 K | 70.000 K | 0.000 | 0.000 | |
| Other Current Assets | 38.717 M | 37.784 M | 47.458 M | 33.870 M | 48.357 M | 29.389 M | 39.777 M | 38.021 M | |
| Short Term Investments | 38.717 M | 37.784 M | 47.458 M | 33.870 M | 48.357 M | 29.389 M | 39.777 M | 38.021 M | |
| Total Receivables | 174.877 M | 115.756 M | 82.465 M | 84.841 M | 68.918 M | 63.143 M | 17.899 M | 24.559 M | |
| Current Cash | 1.377 B | 1.303 B | 1.316 B | 1.206 B | 1.106 B | 1.049 B | 944.073 M | 840.440 M | |
| Total Non-current Assets | 395.371 M | 408.692 M | 1.089 B | 1.090 B | 1.069 B | 884.546 M | 663.593 M | 678.741 M | |
| Property Plant Equipment | 176.221 M | 187.577 M | 314.773 M | 313.973 M | 294.244 M | 201.595 M | 188.193 M | 195.992 M | |
| Other Assets | 53.015 M | 43.928 M | 489.487 M | 485.532 M | 489.376 M | 438.636 M | 264.856 M | 281.412 M | |
| Intangible Assets | 39.180 M | 47.938 M | 111.041 M | 108.736 M | 105.033 M | 100.168 M | 82.741 M | 77.407 M | |
| Goodwill | 30.973 M | 28.804 M | 60.210 M | 58.725 M | 58.829 M | 58.057 M | 49.238 M | 47.909 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.994 B | 1.871 B | 2.539 B | 2.417 B | 2.292 B | 2.026 B | 1.665 B | 1.582 B | |
| Total liabilities | 458.788 M | 435.959 M | 803.044 M | 809.623 M | 788.414 M | 773.709 M | 568.190 M | 594.491 M | |
| Total current liabilities | 135.022 M | 124.818 M | 172.962 M | 191.704 M | 163.331 M | 168.462 M | 163.860 M | 169.043 M | |
| Accounts Payable | 19.459 M | 11.323 M | 10.451 M | 21.571 M | 13.630 M | 10.753 M | 9.323 M | 26.995 M | |
| Other liabilities | 240.596 M | 246.299 M | 216.826 M | 213.821 M | 214.145 M | 201.585 M | 182.495 M | 190.951 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 51.545 M | 59.842 M | 413.256 M | 404.098 M | 410.938 M | 403.662 M | 221.835 M | 234.497 M | |
| Other liabilities | 240.596 M | 246.299 M | 216.826 M | 213.821 M | 214.145 M | 201.585 M | 182.495 M | 190.951 M | |
| Minority interest | 31.625 M | 5.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.535 B | 1.435 B | 1.736 B | 1.608 B | 1.504 B | 1.253 B | 1.097 B | 987.270 M | |
| Common stock | 1.621 B | 1.631 B | 1.857 B | 1.915 B | 1.933 B | 1.951 B | 1.978 B | 2.004 B | |
| Retained earnings | -3.557 B | -4.226 B | -4.398 B | -4.603 B | -4.776 B | -5.079 B | -5.291 B | -5.456 B |